These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 7886000
1. Analysis of tyrosinase mutations associated with tyrosinase-related oculocutaneous albinism (OCA1). Oetting WS, King RA. Pigment Cell Res; 1994 Oct; 7(5):285-90. PubMed ID: 7886000 [Abstract] [Full Text] [Related]
2. Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online. Oetting WS, Fryer JP, King RA. Hum Mutat; 1998 Oct; 12(6):433-4. PubMed ID: 10671066 [Abstract] [Full Text] [Related]
3. Analysis of mutations in the copper B binding region associated with type I (tyrosinase-related) oculocutaneous albinism. Oetting WS, King RA. Pigment Cell Res; 1992 Nov; 5(5 Pt 2):274-8. PubMed ID: 1292009 [Abstract] [Full Text] [Related]
4. Molecular analysis of type I-A (tyrosinase negative) oculocutaneous albinism. Oetting WS, King RA. Hum Genet; 1992 Nov; 90(3):258-62. PubMed ID: 1487241 [Abstract] [Full Text] [Related]
11. Detection of 53 novel DNA variations within the tyrosinase gene and accumulation of mutations in 17 patients with albinism. Opitz S, Käsmann-Kellner B, Kaufmann M, Schwinger E, Zühlke C. Hum Mutat; 2004 Jun; 23(6):630-1. PubMed ID: 15146472 [Abstract] [Full Text] [Related]
12. Molecular basis of oculocutaneous albinism type 1 in Lebanese patients. Zahed L, Zahreddine H, Noureddine B, Rebeiz N, Shakar N, Zalloua P, Haddad F. J Hum Genet; 2005 Jun; 50(6):317-319. PubMed ID: 15937636 [Abstract] [Full Text] [Related]
13. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions. Tripathi RK, Strunk KM, Giebel LB, Weleber RG, Spritz RA. Am J Med Genet; 1992 Jul 15; 43(5):865-71. PubMed ID: 1642278 [Abstract] [Full Text] [Related]
14. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan. Tsai CH, Tsai FJ, Wu JY, Lin SP, Chang JG, Yang CF, Lee CC. Hum Mutat; 1999 Dec 15; 14(6):542. PubMed ID: 10571953 [Abstract] [Full Text] [Related]
15. Mutational analysis of copper binding by human tyrosinase. Spritz RA, Ho L, Furumura M, Hearing VJ. J Invest Dermatol; 1997 Aug 15; 109(2):207-12. PubMed ID: 9242509 [Abstract] [Full Text] [Related]
16. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism. Matsunaga J, Takeda A, Tomita Y, Hara M, Shibahara S, Tagami H. J Dermatol Sci; 1992 May 15; 3(3):181-5. PubMed ID: 1498098 [Abstract] [Full Text] [Related]
17. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism. Park SK, Lee KH, Park KC, Lee JS, Spritz RA, Lee ST. Mol Cells; 1997 Apr 30; 7(2):187-91. PubMed ID: 9163730 [Abstract] [Full Text] [Related]
18. Computational analysis of histidine mutations on the structural stability of human tyrosinases leading to albinism insurgence. Hassan M, Abbas Q, Raza H, Moustafa AA, Seo SY. Mol Biosyst; 2017 Jul 25; 13(8):1534-1544. PubMed ID: 28640309 [Abstract] [Full Text] [Related]